2 Growth Stocks That Might Be Too Cheap to Ignore
There are many ways to determine whether a stock is cheap, but one way of doing so is determining whether there is substantial upside potential for the company. And while the market often bids up shares of companies with excellent prospects, it is possible to find solid stocks still trading at reasonable levels based on their growth potential.
Let's look at two growth stocks with plenty of fuel: Vertex Pharmaceuticals (NASDAQ: VRTX) and Teladoc Health (NYSE: TDOC).
Biotech giant Vertex Pharmaceuticals has had an impressive stock market performance over the past year. That's partly due to the company's consistently strong financial results, which it owes to its monopoly in the cystic fibrosis (CF) drug market. In the first quarter, Vertex revenue jumped by 13% year over year to $2.37 billion.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
Starke Kaufneigung bei Vertex Pharmaceuticals Inc., mit mehr Buy- als Sell-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für Vertex Pharmaceuticals Inc. mit einem Kursziel von 459 € im Vergleich zum aktuellen Kurs von 439.8 €.
